All treatments
Treatment
Wild-Type A Influenza Virus A/Belgium/4217/2015 (H3N2) clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2a Randomized, Double-blind, Placebo-controlled Trial with Open-label Dose-finding Cohorts to Evaluate the Efficacy and Safety of CR9114 Monoclonal Antibody Administered as Intranasal Doses in Healthy Adult Participants who are Challenged with a Live, Wild-type Influenza Type A Virus (A/Belgium/4217/2015 H3N2)
This study is testing a new nose spray medicine called CR9114 for flu. Healthy adults will get a mild flu virus and then either the medicine or a dummy spray to see if it makes them less sick and how safe it is.
For: Influenza virusBelgium - Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase I/IIa, Randomized, Double-Blind, Placebo-Controlled, Single Dose and Single-Dose Challenge Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Intranasal EV25 in Healthy Volunteers and in Influenza Challenge Participants
This study is testing a new nasal spray, EV25, to see if it's safe and helps prevent or treat the flu. It involves healthy volunteers and people intentionally exposed to a flu virus to see how well the spray works.
For: Virus InfluenzaBelgium